These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875 [TBL] [Abstract][Full Text] [Related]
4. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials. Zhang J; Lin L; Zong W Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Zimmet H; Porapakkham P; Porapakkham P; Sata Y; Haas SJ; Itescu S; Forbes A; Krum H Eur J Heart Fail; 2012 Jan; 14(1):91-105. PubMed ID: 22065869 [TBL] [Abstract][Full Text] [Related]
8. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638 [TBL] [Abstract][Full Text] [Related]
9. Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials. Cong XQ; Li Y; Zhao X; Dai YJ; Liu Y J Cardiovasc Transl Res; 2015 Jun; 8(4):221-31. PubMed ID: 25953677 [TBL] [Abstract][Full Text] [Related]
10. [Systematic review on safety of intracoronary autologous bone marrow stem cells transfer in patients with acute myocardial infarction]. Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):679-84. PubMed ID: 19100106 [TBL] [Abstract][Full Text] [Related]
12. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987 [TBL] [Abstract][Full Text] [Related]
13. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Traverse JH; Henry TD; Moye' LA Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659 [TBL] [Abstract][Full Text] [Related]
14. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047 [TBL] [Abstract][Full Text] [Related]
15. Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis. Fisher SA; Dorée C; Brunskill SJ; Mathur A; Martin-Rendon E PLoS One; 2013; 8(6):e64669. PubMed ID: 23840302 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction. Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698 [TBL] [Abstract][Full Text] [Related]
17. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial. Drexler H; Meyer GP; Wollert KC Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634 [TBL] [Abstract][Full Text] [Related]
18. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Kang S; Yang YJ; Li CJ; Gao RL Coron Artery Dis; 2008 Aug; 19(5):327-35. PubMed ID: 18607170 [TBL] [Abstract][Full Text] [Related]
19. Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis. Dahal K; Hendrani A; Sharma SP; Singireddy S; Mina G; Reddy P; Dominic P; Modi K JAMA Intern Med; 2018 Jul; 178(7):913-920. PubMed ID: 29799995 [TBL] [Abstract][Full Text] [Related]
20. Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis. Sterling LH; Filion KB; Atallah R; Reynier P; Eisenberg MJ Int J Cardiol; 2017 Feb; 228():295-302. PubMed ID: 27866018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]